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Experimental 
 
General 
 
Chemicals, solvents and reagents used are commercially available and were used without 
further purification. PE refers to petroleum ether, bp 40-60 °C. Anhydrous solvents were 
used where indicated. Glassware for dry reactions was dried either by heating in an oven 
at 120 °C for at least 1 h, or heating with a hot air gun for 5 min. The glassware was then 
allowed to cool under a stream of N2. 
TLCs were carried out on Merck Aluminium backed TLC plates Silica Gel 60 F254 and 
viewed using UV light of wavelength 254 nm and then stained with potassium 
permanganate. Merck Silica Gel (0.040-0.063 mm) was used for column chromatography. 
Compounds were loaded as an oil, CH2Cl2 solution or dry loaded by adsorption onto 
silica.  
Melting points were obtained using a Reichert-Jung heated-stage microscope. Infrared 
spectra were recorded on a Perkin-Elmer Spectrum RXI FT-IR system and all values are 
recorded in cm−1. 
NMR spectra were obtained on Varian Mercury VX (400 MHz) or Bruker Avance III 
(400 MHz) spectrometers. The chemical shifts are recorded in parts per million (ppm) 
with reference to tetramethylsilane. The coupling constants J are quoted to the nearest 0.5 
Hz and are not corrected. The multiplicities are assigned as a singlet (s), doublet (d), 
triplet (t), quartet (q), doublet of doublets (dd), doublet of doublet of doublets (ddd), 
doublet of triplets (dt), triplet of doublets (td) and multiplet (m). Mass spectra and high 
resolution mass spectra were obtained on a micrOTOFTM from Bruker Daltonics (Bremen, 
Germany) coupled with an electrospray source (ESI-TOF) using an autosampler in an 
Agilent 1100 LC system. Data was processed using external calibration with the Bruker 
Daltonics software, DataAnalysisTM as part of the overall hardware control software, 
Compass 1.1TM. 
 
 
Methyl 3,4,5-trimethoxybenzoate 9, methyl E-3-(3,4,5-trimethoxyphenyl)propenoate 11, 
methyl 3-(3,4,5-trimethoxyphenyl)propanoate 13, methyl E-3-(3,4-dimethoxyphenyl)-
propenoate 15 and methyl 4-hydroxybenzoate 23 were all synthesised from their 
corresponding carboxylic acids following the procedure reported by Parrain1 and gave 
samples that were consistant with the spectroscopic data reported for 9,2 11,1 13,3 154 and 
23.5 
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Methyl 3-(3,4-dimethoxyphenyl)propanoate (17) 
 
MeO
MeO
OMe
O
17  
 
10% Palladium on carbon (50 mg, 0.05 mmol) was added to a vigorously stirred solution 
of methyl 3,4-dimethoxycinnamate (819 mg, 3.69 mmol) in EtOH (20 mL). After 3 cycles 
of purging the flask with N2 then a vacuum, the flask was put under an atmosphere of H2. 
After 2 h, the mixture was filtered through Celite®, washing thoroughly with EtOH, then 
the solvent removed under reduced pressure to afford the methyl propionate 17 (821 mg, 
99%) as a colourless oil without need for further purification. 
1H NMR δH (400 MHz, CDCl3) 6.84 (1H, d, J 8.5 Hz, C5-ArH), 6.77 (1H, dd, J 8.5 and 
2.0 Hz, C6-ArH), 6.76 (1H, d, J 2.0 Hz, C2-ArH), 3.90 (3H, s, ArOMe), 3.88 (3H, s, 
ArOMe), 3.70 (3H, s, CO2Me), 2.93 (2H, t, J 7.5 Hz, ArCH2) and 2.64 (2H, t, J 7.5 Hz, 
CH2CO2Me); 13C NMR δC (100 MHz, CDCl3) 173.4, 149.0, 147.6, 133.2, 120.1, 111.8, 
111.4, 56.0, 55.9, 51.6, 36.0 and 30.6. 
Consistent with the spectroscopic data previously reported.6  
 
 
General procedure: Formation of prenylated and chroman compounds  
Bi(OTf)3 (136 mg, 0.2 mmol) was added to a vigorously stirred solution of the arene (2 
mmol) and isoprene (400 µl, 4 mmol) in anhydrous toluene (10 mL) in a thick-walled 
pressure tube at room temperature under Ar. The tube was sealed and the reaction heated 
at 40 °C for between 75 min and 24 h and the crude reaction mixture (often dark 
purple/black in colour) was applied directly to a silica gel chromatography column to 
afford the purified product(s). Representative reactions have also been performed in a 
conventional round-bottomed flask with a tightly fitted stopper to afford similar results.  
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1,2,3-Trimethoxy-4-(3-methylbut-2-en-1-yl)benzene (6a) and 2,3,4-trimethoxy-1,5-bis(3-
methylbut-2-en-1-yl)benzene (6b) 
MeO
MeO
OMe
6a
MeO
MeO
OMe
6b  
 
 
Following the general procedure, 1,2,3-trimethoxybenzene 5 (336 mg, 2 mmol) gave, 
after 75 min and subsequent column chromatography [silica, PE-Et2O gradient from 
100:0 to 90:10], the mono-product 6a (292 mg, 62%) and the bis-product 6b (122 mg, 
20%) as colourless oils. 
 
Mono-product (6a) 
IR νmax (thin film) 2936, 1599, 1495, 1464, 1416, 1294, 1256, 1096 and 1017; 1H NMR 
δH (400 MHz, CDCl3) 6.86 (1H, d, J 8.5 Hz, ArH), 6.64 (1H, d, J 8.5 Hz, ArH), 5.28 (1H, 
triplet of septets, J 7.5 and 1.5 Hz, CH=CMe2), 3.91 (3H, s, OMe), 3.90 (3H, s, OMe), 
3.87 (3H, s, OMe), 3.31 (2H, d, J 7.5 Hz, ArCH2), 1.77 (3H, br s, CH=CMeAMeB) and 
1.77 (3H, br s, CH=CMeAMeB); 13C NMR δC (100 MHz, CDCl3) 152.0, 151.8, 142.4, 
132.0, 127.9, 123.5, 123.3, 107.4, 60.7, 60.7, 56.0, 28.2, 25.7 and 17.7. 
Consistent with the spectroscopic data previously reported.7 
 
Bis-product (6b) 
IR νmax (thin film) 2965, 2931, 1479, 1460, 1411, 1325, 1235, 1092, 1065 and 1015; 1H 
NMR δH (400 MHz, CDCl3) 6.67 (1H, s, ArH), 5.25 (2H, triplet of septets, J 7.0 and 1.5 
Hz, CH=CMe2), 3.91 (3H, s, OMe), 3.83 (6H, s, OMe), 3.27 (4H, d, J 7.0 Hz, ArCH2) and 
1.74 (12H, d, J 1.5 Hz, CH=CMe2); 13C NMR δC (100 MHz, CDCl3) 149.8, 146.3, 132.0, 
130.3, 124.2, 123.3, 60.8, 60.6, 28.4, 25.7 and 17.8; MS (+ESI) m/z 305 (MH+, 9%); 
HRMS (+ESI) Found MH+, 305.2103; C19H29O3 requires MH+ 305.2117. 
 
 
 
 
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S5
 
1-Bromo-3,4,5-trimethoxy-2-(3-methylbut-2-en-1-yl)benzene (8) 
 
MeO
MeO
OMe
8
Br
 
 
Following the general procedure, the aryl bromide 7 (494 mg, 2 mmol) gave, after 7 h and 
subsequent column chromatography [silica, PE-Et2O gradient from 100:0 to 95:5], the 
product 8 (275 mg, 44%) as a colourless oil in addition to recovered starting material 7 
(246 mg, 50%). 
Rf [PE-Et2O 70:30] 0.63; IR νmax (thin film) 2935, 1590, 1482, 1452, 1430, 1396, 1313, 
1270, 1237, 1195, 1156, 1113, 1045 and 1019; 1H NMR δH (400 MHz, CDCl3) 6.87 (1H, 
s, ArH), 5.12 (1H, triplet of septets, J 7.0 and 1.5 Hz, CH=CMe2), 3.84, (6H, s, OMe), 
3.82 (3H, s, OMe), 3.42, (2H, d, J 7.0 Hz, ArCH2), 1.79 (3H, br s, CH=CMeAMeB) and 
1.68 (3H, d, J 1.0 Hz, CH=CMeAMeB); 13C NMR δC (100 MHz, CDCl3) 152.6, 152.1, 
142.0, 131.8, 128.1, 122.1, 117.9, 112.0, 61.1, 60.7, 56.2, 29.3, 25.7 and 18.1; MS (+ESI) 
m/z 315 (MH+, 97%), 317 (MH+, 100) and 337 (MNa+, 23); HRMS (+ESI) Found MNa+, 
337.0400; C14H1979BrNaO3 requires MNa+ 337.0415. 
 
Methyl 3,4,5-trimethoxy-2-(3-methylbut-2-en-1-yl)benzoate (10)  
MeO
MeO
OMe
10
O
OMe
 
 
Following the general procedure, ester 9 (452 mg, 2 mmol) gave, after 5 h and subsequent 
column chromatography [silica, PE-Et2O gradient from 100:0 to 95:5], the product 10 (87 
mg, 15%) as a colourless oil in addition to ester 9 (384 mg, 85%). 
IR νmax (thin film) 2939, 1723 (C=O), 1594, 1491, 1455, 1431, 1401, 1337, 1222, 1154, 
1115 and 1055; 1H NMR δH (400 MHz, CDCl3) 7.17 (1H, s, ArH), 5.12 (1H, triplet of 
septets, J 6.5 and 1.5 Hz, CH=CMe2), 3.91 (3H, s, OMe), 3.86 (3H, s, OMe), 3.86 (3H, s, 
OMe), 3.82 (3H, s, OMe), 3.62 (2H, d, J 6.5 Hz, ArCH2), 1.75 (3H, d, J 0.5 Hz, 
CH=CMeAMeB) and 1.66 (3H, d, J 1.0 Hz, CH=CMeAMeB); 13C NMR δC (100 MHz, 
CDCl3) 168.0, 152.3, 151.0, 145.7, 131.1, 130.7, 125.2, 123.8, 109.7, 61.0, 60.7, 56.1, 
52.0, 25.9, 25.7 and 17.9; MS (+ESI) m/z 295 (MH+, 29%) and 317 (MNa+, 12); HRMS 
(+ESI) Found MH+, 295.1551; C16H23O5 requires MH+ 295.1546. 
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Methyl E-3-(3,4,5-trimethoxy-2-(3-methylbut-2-en-1-yl)phenyl)propenoate (12) 
 
MeO
MeO
OMe
12
O
OMe
 
 
Following the general procedure, ester 11 (504 mg, 2 mmol) gave, after 4 h and 
subsequent column chromatography [silica, PE-Et2O gradient from 100:0 to 90:10], the 
mono-product 12 (302 mg, 47%) as a colourless oil in addition to ester 11 (90 mg, 18%). 
IR νmax (thin film) 2937, 1719 (C=O), 1631, 1592, 1566, 1487, 1409, 1347, 1289, 1254, 
1168, 1124; 1H NMR δH (400 MHz, CDCl3) 7.92 (1H, d, J 15.5 Hz, CH=CHCO2Me), 
6.87 (1H, s, ArH), 6.26 (1H, d, J 15.5 Hz, CH=CHCO2Me), 5.02 (1H, t, J 6.5 Hz, 
CH=CMe2), 3.89 (3H, s, OMe), 3.86 (3H, s, OMe), 3.83 (3H, s, OMe), 3.79 (3H, s, OMe), 
3.42 (2H, d, J 6.5 Hz, ArCH2), 1.81 (3H, s, CH=CMeAMeB) and 1.67 (3H, s, 
CH=CMeAMeB); 13C NMR δC (100 MHz, CDCl3) 167.4, 151.9, 151.7, 144.2, 142.6, 
131.6, 129.0, 128.6, 123.1, 118.0, 105.3, 61.0, 60.8, 55.9, 51.6, 25.7, 25.0 and 17.9; MS 
(+ESI) m/z 343 (MNa+, 11%); HRMS (+ESI) Found MNa+, 343.1508; C18H24NaO5 
requires MNa+ 343.1521. 
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Methyl 3-(3,4,5-trimethoxy-2-(3-methylbut-2-en-1-yl)phenyl)propanoate (14a) and 
methyl 3-(3,4,5-trimethoxy-2,6-bis(3-methylbut-2-en-1-yl)phenyl)propanoate (14b) 
 
MeO
MeO
OMe
14a
O
OMe
MeO
MeO
OMe
14b
O
OMe
 
 
 
Following the general procedure, ester 13 (508 mg, 2 mmol) gave, after 90 min and 
subsequent column chromatography [silica, PE-Et2O gradient from 100:0 to 80:20], the 
mono-product 14a (376 mg, 58%) and the bis-product 14b (233 mg, 30%) as colourless 
oils. 
 
Mono-product (14a) 
Rf [PE-Et2O 80:20] 0.27; IR νmax (thin film) 2935, 1739 (C=O), 1599, 1578, 1494, 1453, 
1406, 1338, 1283, 1239, 1196, 1121, 1073 and 1042; 1H NMR δH (400 MHz, CDCl3) 6.53 
(1H, s, ArH), 5.08-5.04 (1H, m, CH=CMe2), 3.87 (3H, s, OMe), 3.86 (3H, s, OMe), 3.84 
(3H, s, OMe), 3.71 (3H, s, OMe), 3.33 (2H, d, J 6.5 Hz, ArCH2CH=CMe2), 2.93-2.89 
(2H, m, ArCH2CH2CO2Me) 2.60-2.56 (2H, m, CH2CO2Me), 1.79 (3H, br s, 
CH=CMeAMeB) and 1.71 (3H, d, J 1.0 Hz, CH=CMeAMeB); 13C NMR δC (100 MHz, 
CDCl3) 173.4, 152.1, 151.5, 140.9, 134.2, 131.1, 126.2, 123.8, 108.4, 60.9, 60.7, 56.0, 
51.6, 35.5, 28.3, 25.6, 25.2 and 17.8; MS (+ESI) m/z 345 (MNa+, 24%); HRMS (+ESI) 
Found MNa+, 345.1661; C18H26NaO5 requires MNa+ 345.1678. 
 
Bis-product (14b) 
Rf [PE-Et2O 80:20] 0.51; IR νmax(thin film) 2948, 2933, 1740 (C=O), 1463, 1416, 1334, 
1195, 1170, 1096, 1048 and 982; 1H NMR δH (400 MHz, CDCl3) 5.10-5.06 (2H, m, 
CH=CMeAMeB), 3.91 (3H, s, OMe), 3.85 (6H, s, OMe), 3.72 (3H, s, OMe), 3.36 (4H, d, J 
6.5 Hz, ArCH2CH=CMe2), 2.93-2.89 (2H, m, ArCH2CH2CO2Me), 2.50-2.46 (2H, m, 
CH2CO2Me), 1.79 (6H, d, J 1.0 Hz, CH=CMeAMeB) and 1.71 (6H, d, J 1.0 Hz, 
CH=CMeAMeB); 13C NMR δC (100 MHz, CDCl3) 173.4, 150.3, 144.8, 133.0, 131.1, 
129.5, 124.0, 60.8, 60.4, 51.5, 34.9, 25.7, 25.6, 24.8 and 17.8; MS (+ESI) m/z 391 (MH+, 
20%); HRMS (+ESI) Found MH+, 391.2652; C23H35O5 requires MH+ 391.2485. 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S8
 
Methyl E-3-(4,5-dimethoxy-2-(3-methylbut-2-en-1-yl)phenyl)propenoate (16) 
 
MeO
MeO
16
O
OMe
 
 
Following the general procedure, ester 15 (446 mg, 2 mmol) gave, after 6 h and 
subsequent column chromatography [silica, PE-Et2O gradient from 100:0 to 90:10], the 
mono-product 16 (100 mg, 17%) as a colourless oil. 
IR νmax (thin film) 2934, 1715 (C=O), 1602, 1514, 1458, 1268, 1167 and 1102; 1H NMR 
δH (400 MHz, CDCl3) 7.95 (1H, d, J 16.0 Hz, CH=CHCO2Me), 7.05 (1H, s, ArH), 6.68 
(1H, s, ArH), 6.24 (1H, d, J 16.0 Hz, CH=CHCO2Me), 5.16 (1H, triplet of septets, J 7.0 
and 1.5 Hz, CH=CMe2), 3.87 (3H, s, OMe), 3.87 (3H, s, OMe), 3.78 (3H, s, OMe), 3.40 
(2H, d, J 7.0 Hz, ArCH2), 1.76 (3H, br s, CH=CMeAMeB) and 1.71 (3H, d, J 1.0 Hz, 
CH=CMeAMeB); 13C NMR δC (100 MHz, CDCl3) 167.7, 151.0, 147.6, 142.1, 135.5, 
132.6, 125.0, 122.9, 116.3, 112.6, 109.0, 56.0, 55.9, 51.5, 31.8, 25.7 and 17.9; MS (+ESI) 
m/z 313 (MNa+, 9%); HRMS (+ESI) Found MNa+, 313.1424; C17H22NaO4 requires MNa+ 
313.1416. 
 
Methyl 3-(4,5-dimethoxy-2-(3-methylbut-2-en-1-yl)phenyl)propanoate (18) 
MeO
MeO
18
O
OMe
 
 
Following the general procedure, ester 17 (448 mg, 2 mmol) gave, after 6 h and 
subsequent column chromatography [silica, PE-Et2O gradient from 100:0 to 90:10], the 
mono-product 18 (376 mg, 64%) as a colourless oil. 
Rf [PE-Et2O 50:50] 0.32; IR νmax (thin film) 2934, 2851, 1737 (C=O), 1516, 1458, 1361, 
1271, 1209 and 1093; 1H NMR δH (400 MHz, CDCl3) 6.69 (1H, s, ArH), 6.69 (1H, s, 
ArH), 5.21 (1H, triplet of septets, J 7.0 and 1.5 Hz, CH=CMe2), 3.85 (3H, s, OMe), 3.85 
(3H, s, OMe), 3.69 (3H, s, OMe), 3.29 (2H, d, J 7.0 Hz, ArCH2CH=CMe2), 2.92-2.88 
(2H, m, ArCH2CH2CO2Me), 2.59-2.55 (2H, m, CH2CO2Me), 1.75 (3H, br s, 
CH=CMeAMeB) and 1.74 (3H, br s, CH=CMeAMeB); 13C NMR δC (100 MHz, CDCl3) 
173.4, 147.5, 147.2, 132.1, 131.7, 130.4, 123.4, 113.0, 112.7, 56.0, 55.9, 51.5, 35.5, 31.3, 
27.8, 25.7 and 17.9; MS (+ESI) m/z 293 (MH+, 15%) and 315 (MNa+, 27); HRMS (+ESI) 
Found MH+, 293.1723; C17H25O4 requires MH+ 293.1753. 
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1-(2,2-Dimethylchroman-6-yl)ethanone (20) 
 
O
O
20
 
 
Following the general procedure, phenol 19 (272 mg, 2 mmol) gave, after 18 h and 
subsequent column chromatography [silica, PE-Et2O-EtOAc gradient from 100:0:0 to 
85:15:0 then 50:0:50], the chroman 20 (235 mg, 58%) as a white solid in addition to 
phenol 19 (62 mg, 23%). 
Rf [PE-Et2O 70:30] 0.63; Mp 89-93 °C (from CH2Cl2); IR νmax (thin film) 2976, 1670 
(C=O), 1537, 1498, 1419, 1358, 1289, 1265, 1156 and 1117; 1H NMR δH (400 MHz, 
CDCl3) 7.75 (1H, d, J 2.5 Hz, C5-ArH), 7.73 (1H, dd, J 8.5 and 2.5 Hz, C7-ArH), 6.81 
(1H, d, J 8.5 Hz, C8-ArH), 2.83 (2H, t, J 6.5 Hz, C4-CH2), 2.54 (3H, s, COMe), 1.84 (2H, 
t, J 6.5 Hz, C3-CH2) and 1.37 (6H, s, CMe2); 13C NMR δC (100 MHz, CDCl3) 196.9, 
158.6, 130.5, 129.4, 128.3, 120.7, 117.2, 75.5, 32.5, 26.9, 26.2 and 22.4. 
Consistent with the spectroscopic data previously reported.8 
 
2,2-Dimethylchroman-6-carboxylic acid (22) 
 
O
OH
O
22
 
 
Following the general procedure, phenol 21 (276 mg, 2 mmol) gave, after 24 h and 
subsequent column chromatography [silica, PE-EtOAc gradient from 100:0 to 40:60], the 
chroman 22 (14 mg, 3%) as a white solid in addition to phenol 21 (254 mg, 92%). 
IR νmax (thin film) 2975, 1681 (C=O), 1608, 1578, 1443, 1411, 1324, 1296, 1265, 1156 
and 1120; 1H NMR δH (400 MHz, CDCl3) 7.86 (1H, d, J 2.0 Hz, C5-ArH), 7.84 (1H, dd, J 
8.5 and 2.0 Hz, C7-ArH), 6.82 (1H, d, J 8.5 Hz, C8-ArH), 2.84 (2H, t, J 7.0 Hz, C4-CH2), 
1.84 (2H, t, J 7.0 Hz, C3-CH2) and 1.36 (6H, s, CMe2); 13C NMR δC (100 MHz, CDCl3) 
172.1, 159.1, 132.4, 129.9, 120.8, 120.7, 117.4, 75.6, 32.5, 26.9 and 22.3; MS (+ESI) m/z 
207 (MH+, 100%) and 229 (MNa+, 45); HRMS (+ESI) Found MH+, 207.1033; C12H15O3 
requires MH+ 207.1021. 
Consistent with the spectroscopic data previously reported.9 
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Methyl 2,2-dimethylchroman-6-carboxylate (24) 
 
O
OMe
O
24
 
 
Following the general procedure, phenol 23 (304 mg, 2 mmol) gave, after 5 h and 
subsequent column chromatography [silica, PE-Et2O gradient from 100:0 to 85:15] the 
chroman 24 (285 mg, 65%) as a white solid in addition to phenol 23 (32 mg, 11%). 
Rf [PE-Et2O 70:30] 0.61; IR νmax (thin film) 2975, 2948, 1716 (C=O), 1613, 1581, 1493, 
1437, 1290, 1263, 1155 and 1118; 1H NMR δH (400 MHz, CDCl3) 7.78 (1H, d, J 2.0 Hz, 
C5-ArH), 7.76 (1H, dd, J 8.5 and 2.0 Hz, C7-ArH), 6.77 (1H, d, J 8.5 Hz, C8-ArH), 3.86 
(3H, s, OMe), 2.80 (2H, t, J 7.0 Hz, C4-CH2), 1.82 (2H, t, J 7.0 Hz, C3-CH2) and 1.34 
(6H, s, CMe2); 13C NMR δC (100 MHz, CDCl3) 167.1, 158.3, 131.6, 129.1, 121.5, 120.6, 
117.2, 75.3, 51.7, 32.6, 26.9 and 22.3. 
Consistent with the spectroscopic data previously reported.10 
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1-(7-Hydroxy-2,2-dimethylchroman-6-yl)ethanone (26), 1-(5-hydroxy-2,2-
dimethylchroman-8-yl)ethanone (27) and 1-(2,2,8,8-tetramethyl-2,3,4,8,9,10-
hexahydropyrano[2,3-f]chromen-6-yl)ethanone (28) 
O
O
26
OH
O
HO
27
O
O
O
28
O
 
 
Following general procedure, phenol 25 (304 mg, 2 mmol) gave, after 8 h and subsequent 
column chromatography [silica, PE-EtOAc gradient from 100:0 to 70:30], the chroman 
products 26 (105 mg, 24%) as a white solid, 27 (46 mg, 10%) as a white solid and 28 (77 
mg, 13%) as a colourless oil. 
Chroman (26) 
Mp 115-118 °C (from EtOAc); lit.12 118-119 °C; IR νmax (thin film) 2937, 2957, 1867, 
1647 (C=O), 1612, 1495, 1369, 1288, 1280, 1161, 1118, 1058 1020 and 885; 1H NMR δH 
(400 MHz, CDCl3) 12.30 (1H, s, OH), 7.41 (1H, s, C5-ArH), 6.28 (1H, s, C8-ArH), 2.71 
(2H, t, J 7.0 Hz, C4-CH2), 2.70 (3H, s, COMe), 1.80 (2H, t, J 7.0 Hz, C3-CH2) and 1.33 
(6H, s, CMe2); 13C NMR δC (100 MHz, CDCl3) 202.3, 162.8, 161.4, 132.2, 113.9, 112.7, 
104.6, 75.9, 32.7, 26.4, 26.1 and 21.7.  
Consistent with the spectroscopic data previously reported.11,12 
 
Chroman (27) 
Mp 165-170 °C (from EtOAc); IR νmax (thin film) 3172, 2974, 2931, 1638 (C=O), 1583, 
1433, 1362, 1277, 1217, 1157, 1119 and 1051; 1H NMR δH (400 MHz, CDCl3) 7.68 (1H, 
d, J 8.5 Hz, C7-ArH), 7.20 (1H, broad s, OH), 6.47 (1H, d, J 8.5 Hz, C6-ArH), 2.74 (2H, 
t, J 7.0 Hz, C4-CH2), 2.64 (3H, s, COMe), 1.87 (2H, t, J 7.0 Hz, C3-CH2) and 1.43 (6H, s, 
CMe2); 13C NMR δC (100 MHz, CDCl3) 199.7, 159.2, 156.4, 129.9, 120.3, 108.5, 107.0, 
75.3, 32.2, 31.6, 26.9 and 17.0. 
 
Chroman (28) 
IR νmax (thin film) 2974, 2933, 1662 (C=O), 1603, 1579, 1457, 1357, 1298, 1258, 1178, 
1154, 1120 and 1096; 1H NMR δH (400 MHz, CDCl3) 7.48 (1H, s, C5-ArH), 2.70 (2H, t, 
J 7.0 Hz, C4-CH2), 2.60 (2H, t, J 7.0 Hz, C10-CH2), 2.56 (3H, s, COMe), 1.76 (2H, t, J 
7.0 Hz, C9-CH2), 1.76 (2H, t, J 7.0 Hz, C3-CH2), 1.35 (6H, s, C(8)-CMe2) and 1.32 (6H, 
s, C2-CMe2); 13C NMR δC (100 MHz, CDCl3) 198.6, 156.2, 153.8, 129.2, 120.0, 111.9, 
109.4, 75.3, 74.7, 32.8, 32.3, 31.8, 27.1, 26.8, 21.7 and 17.2. 
Consistent with the spectroscopic data previously reported.12 
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5,6,7-Trimethoxy-2,2-dimethylchroman (32) and 3,4,5-trimethoxy-4-(3-methylbut-2-en-
1-yl)-cyclohexa-2,5-dienone (33) 
 
MeO
MeO
OMe
O
32
O
OMe
MeO
MeO
33  
 
Following the general procedure, phenol 30 (368 mg, 2 mmol) gave, after 18 h and 
subsequent column chromatography [silica, PE-Et2O gradient from 100:0 to 85:15 then 
PE-EtOAc gradient from 50:50 to 30:70], the chroman product 32 (279 mg, 55%) as a 
colourless oil and the dienone 33 (132 mg, 26%) as a white solid. 
 
Chroman (32) 
Rf [PE-Et2O 80:20] 0.52; IR νmax (thin film) 2973, 2937, 1611, 1489, 1460, 1413, 1324, 
1203, 1158, 1131, 1098, 1045 and 1013; 1H NMR δH (400 MHz, CDCl3) 6.15 (1H, s, C8-
ArH), 3.87 (3H, s, C6-OMe), 3.79 (3H, s, C5-OMe), 3.78 (3H, s, C7-OMe), 2.63 (2H, t, J 
7.0 Hz, C4-CH2), 1.73 (2H, t, J 7.0 Hz, C3-CH2), 1.30 (3H, s, C2-CMeAMeB) and 1.28 
(3H, s, C2-CMeAMeB); 13C NMR δC (100 MHz, CDCl3) 152.4, 151.4, 150.0, 135.4, 106.7, 
96.6, 74.0, 61.0, 60.5, 55.8, 32.4, 26.7, 26.7 and 17.0. 
Consistent with the spectroscopic data previously reported.13 
 
Dienone (33) 
Rf [PE-EtOAc 40:60] 0.50; Mp 106-109 °C (from CH2Cl2); IR νmax (thin film) 2934, 
2852, 1659 (C=O), 1625, 1597, 1459, 1374, 1240, 1215, 1163, 1078 and 888; 1H NMR 
δH (400 MHz, CDCl3) 5.56 (2H, s, C2/C6-CH), 4.66 (1H, triplet of septets, J 7.5 and 1.5 
Hz, CH=CMe2), 3.73 (6H, s, C3/C5-OMe), 3.08 (3H, s, C4-OMe), 2.67 (2H, d, J 7.5 Hz, 
CH2CH=CMe2), 1.56 (3H, br s, CH=CMeAMeB) and 1.52 (3H, br s, CH=CMeAMeB); 13C 
NMR δC (100 MHz, CDCl3) 187.3, 169.4, 136.3, 115.7, 104.3, 79.4, 56.0, 52.5, 35.6, 25.7 
and 17.6; MS (+ESI) m/z 253 (MH+); HRMS (+ESI) Found MH+, 253.1427; C14H21O4 
requires MH+ 253.1440. 
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3,4,5-Trimethoxy-2-(3-methylbut-2-en-1-yl)-phenyl acetate (35a) and 3,4,5-trimethoxy-
2,6-bis(3-methylbut-2-en-1-yl)phenyl acetate (35b) 
 
MeO
MeO
OMe
O
35a
O
MeO
MeO
OMe
O
35b
O
 
 
Incorporating the procedure reported by Mohammadpoor-Baltork,14 Ac2O (283 µl, 3 
mmol) was added to a rapidly stirred suspension of Bi(OTf)3 (136 mg, 0.2 mmol) and 
phenol 30 (368 mg, 2 mmol) in anhydrous toluene (10 mL) in a thick-walled pressure 
tube at room temperature under Ar. After 5 min, isoprene (400 µl, 4 mmol) was added to 
the solution and the tube was sealed and the reaction heated at 40 °C for 1 h. Column 
chromatography [silica, PE-Et2O gradient from 100:0 to 90:10] gave the mono-prenylated 
product 35a (414 mg, 70%) and the bis-prenylated product 35b (108 mg, 15%) as 
colourless oils. 
 
Mono-product (35a) 
Rf [PE-Et2O 80:20] 0.37; IR νmax (thin film) 2937, 1767 (C=O), 1608, 1490, 1456, 1408, 
1368, 1339, 1206, 1122, 1075 and 1042; 1H NMR δH (400 MHz, CDCl3) 6.38 (1H, s, C6-
ArH), 5.06 (1H, triplet of septets, J 7.0 and 1.5 Hz, CH=CMe2), 3.85 (3H, s, OMe), 3.84 
(3H, s, OMe), 3.80 (3H, s, OMe), 3.17 (2H, d, J 7.0 Hz, ArCH2), 2.27 (3H, s, Ac), 1.73 
(3H, br s, CH=CMeAMeB) and 1.66 (3H, d, J 1.0 Hz, CH=CMeAMeB); 13C NMR δC (100 
MHz, CDCl3) 169.5, 152.3, 151.7, 144.5, 140.5, 131.3, 122.7, 120.1, 102.4, 61.0, 60.8, 
56.0, 25.6, 23.5, 20.8 and 17.7; MS (+ESI) m/z 295 (MH+, 24%), 317 (MNa+, 20); HRMS 
(+ESI) Found MH+, 295.1533; C16H23O5 requires MH+ 295.1546. 
 
Bis-product (35b) 
Rf [PE-Et2O 80:20] 0.61; IR νmax (thin film) 2935, 1765 (C=O), 1600, 1463, 1416, 1367, 
1346, 1204, 1097,. 1048 and 982; 1H NMR δH (400 MHz, CDCl3) 5.08 (2H, triplet of 
septets, J 7.0 and 1.5 Hz, CH=CMe2), 3.87 (3H, s, C4-OMe), 3.82 (6H, s, C3/5-OMe), 
3.16 (4H, broad s, ArCH2), 2.52 (3H, s, Ac), 1.73 (6H, d, J 1.0 Hz, CH=CMeAMeB) and 
1.73 (6H, d, J 1.0 Hz, CH=CMeAMeB); 13C NMR δC (100 MHz, CDCl3) 169.3, 150.3, 
144.8, 143.2, 131.3, 123.7, 122.7, 61.0, 60.6, 25.6, 24.1, 20.6 and 17.8; MS (+ESI) m/z 
363 (MH+, 5%) and 385 (MNa+, 14); HRMS (+ESI) Found MNa+, 385.1975 C21H30NaO5 
requires MNa+ 385.1991. 
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General Procedure: Deacetylation of aromatic acetates 
Method A: Following a procedure reported by Bates et al. but at a different 
concentration,15 K2CO3 (2 equiv.) was added to a solution of the acetate (1 equiv.) in 
MeOH (5 mL/mmol) at room temperature and the reaction was stirred for 2 h. The 
suspension was quenched with saturated aqueous NH4Cl (30 mL) and extracted with 
EtOAc (3 × 15 mL). The combined organic fractions were washed with saturated brine 
(15 mL), dried over anhydrous Na2SO4, filtered and the solvent removed under reduced 
pressure. Column chromatography [silica, PE-EtOAc gradient from 100:1 to 75:25] 
afforded the phenol product. 
 
Method B: Following a procedure reported by Narender et al.,16 NaOAc (10 equiv.) was 
added to a solution of the acetate (1 equiv.) in EtOH/H2O (10:1, 5.5 mL/mmol) and the 
reaction heated at reflux for 5 h. After cooling, the reaction was diluted with H2O (15 mL) 
and extracted with EtOAc (3 × 15 mL). The organic fractions were combined, washed 
with saturated brine (15 mL), dried over anhydrous Na2SO4, filtered and the solvent 
removed under reduced pressure. Column chromatography [silica, PE-EtOAc gradient 
from 100:1 to 75:25] afforded the phenol product. 
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3,4,5-Trimethoxy-2-(3-methylbut-2-en-1-yl)phenol (31a) 
MeO
MeO
OMe
OH
31a
 
 
Following Method A, acetate 35a (411 mg, 1.4 mmol) gave the phenol 31a (173 mg, 
49%) as a yellow amorphous solid. Following Method B, acetate 35a (132 mg, 0.45 
mmol) gave the phenol 31a (41 mg, 36%) as a yellow amorphous solid, in addition to 
acetate 35a (53 mg, 40%). 
Rf [PE-EtOAc 75:25] 0.25; IR νmax (thin film) 3392, 2963, 1935, 1607, 1505, 1463, 1415, 
1357, 1237, 1197, 1164, 1126, 1082, 1040 and 993; 1H NMR δH (400 MHz, CDCl3) 6.20 
(1H, s, C6-ArH), 5.70 (1H, s, OH), 5.19 (1H, triplet of septets, J 7.0 and 1.5 Hz, 
CH=CMe2), 3.83 (3H, s, OMe), 3.79 (3H, s, OMe), 3.72 (3H, s, OMe), 3.31 (2H, d, J 7.0 
Hz, ArCH2), 1.78 (3H, d, J 1.0 Hz, CH=CMeAMeB) and 1.70 (3H, d, J 1.0 Hz, 
CH=CMeAMeB); 13C NMR δC (100 MHz, CDCl3) 151.9, 151.9, 150.9, 136.1, 133.6, 
122.6, 113.0, 96.6, 61.2, 61.0, 55.9, 25.7, 22.8 and 17.8; MS (+ESI) m/z 253 (MH+ 100%) 
and 275 (MNa+, 92); HRMS (+ESI) Found MNa+, 275.1272 C14H20NaO4 requires MNa+ 
275.1259. 
Consistent with the spectroscopic data previously reported.17 
 
3,4,5-Trimethoxy-2,6-bis(3-methylbut-2-en-1-yl)phenol (31b) 
MeO
MeO
OMe
OH
31b
 
 
Following Method A, acetate 35b (100 mg, 0.27 mmol) gave the phenol 31b (28 mg, 
32%) as a colourless oil. 
IR νmax (thin film) 3461, 2964, 2933, 1605, 1462, 1418, 1357, 1256, 1171, 1097, 1051 and 
987; 1H NMR δH (400 MHz, CDCl3) 5.59 (1H, s, OH), 5.21 (2H, triplet of septets, J 7.0 
and 1.5 Hz, CH=CMe2), 3.85 (3H, s, C4-OMe), 3.84 (6H, s, C3/5-OMe), 3.34 (4H, d, J 
7.0 Hz, ArCH2), 1.80 (6H, d, J 1.0 Hz, CH=CMeAMeB) and 1.72 (6H, d, J 1.0 Hz, 
CH=CMeAMeB); 13C NMR δC (100 MHz, CDCl3) 150.1, 149.2, 140.3, 133.4, 122.6, 
116.8, 61.1, 60.9, 25.8, 23.1 and 17.8; MS (+ESI) m/z 321 (MH+, 50%); HRMS (+ESI) 
Found MH+, 321.2066; C19H29O4 requires MH+ 321.2066.  
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3,4,5-Trimethoxy-2-(3-methylbut-2-en-1-yl)phenol (31a) and 1-(6-hydroxy-2,3,4-
trimethoxyphenyl)ethanone (36) 
 
MeO
MeO
OMe
OH
31a
MeO
MeO
OMe
OH
36
O
 
 
Incorporating the procedure reported by Mohammadpoor-Baltork,14 Ac2O (283 µl, 3 
mmol) was added to a rapidly stirred suspension of Bi(OTf)3 (136 mg, 0.2 mmol) and 
phenol 30 (368 mg, 2 mmol) in anhydrous toluene (10 mL) in a thick-walled pressure 
tube at room temperature under Ar. After 5 min, isoprene (400 µl, 4 mmol) was added to 
the solution and the tube was sealed and the reaction heated at 40 °C for 4 h. The solvent 
was removed and following the procedure reported by Bates et al.,15 the residue was 
dissolved in MeOH (10 mL) and K2CO3 (552 mg, 4 mmol) was added. The reaction was 
stirred for 50 min at room temperature and then quenched with saturated aqueous NH4Cl 
(30 mL) and extracted with CH2Cl2 (3 × 30 mL). The combined organic fractions were 
washed with saturated brine (30 mL), dried over anhydrous Na2SO4, filtered and the 
solvent removed under reduced pressure. Column chromatography [silica, PE-EtOAc 
gradient from 100:0 to 70:30] gave the mono-prenylated product 31a (223 mg, 44%), 
consistent with the spectroscopic data reported, in addition to the acetophenone product 
36 (39 mg, 9%) as colourless oils. 
 
Acetophenone product (36) 
1H NMR δH (400 MHz, CDCl3) 13.39 (1H, s, OH), 6.22 (1H, s, C5-ArH), 3.97 (3H, s, 
OMe), 3.87 (3H, s, OMe), 3.76 (3H, s, OMe) and 2.63 (3H, s, COMe); 13C NMR δC (100 
MHz, CDCl3) 203.3, 161.9, 160.1, 155.2, 134.8, 108.5, 96.1, 61.0, 60.9, 56.0 and 31.8. 
Consistent with the spectroscopic data previously reported.18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S17
 
References 
 
 
(1) J. Bourdron, L. Commeiras, P. Barbier, V. Bourgarel-Rey, E. Pasquier, N. Vanthuyne, J.-C. 
Hubaud, V. Peyrot and J.-L. Parrain, Bioorg. Med. Chem., 2006, 14, 5540. 
(2)  P. W. Elsinghorst, C. M. González Tanarro and M. Gütschow, J. Med. Chem., 2006, 49, 7540. 
(3)  V. Kumar, A. Sharma and A. K. Sinha, Helv. Chim. Acta, 2006, 89, 483. 
(4) A. El-Batta, C. Jiang, W. Zhao, R. Anness, A. L. Cooksy and M. Bergdahl, J. Org. Chem., 
2007, 72, 5244. 
(5) R. Gopinath and B. K. Patel, Org. Lett., 2000, 2, 577.  
(6)  D. d. L. Moreira, E. F. Guimarães and M. A. C. Kaplan, Phytochemistry, 2000, 55, 783. 
(7)  M. A. Tarselli, A. Liu and M. R. Gagné, Tetrahedron, 2009, 65, 1785. 
(8)  T. Narender, K. P. Reddy and Shweta, Synth. Commun., 2009, 39, 384. 
(9)  M. O. Fatope and D. J. Abraham, J. Med. Chem., 1987, 30, 1973. 
(10) V. K. Ahluwalia, R. S. Jolly and A. K. Tehim, Tetrahedron, 1982, 38, 3673. 
(11) Q. Wang, X. She, X. Ren, J. Ma and X. Pan, Tetrahedron: Asymmetry, 2004, 15, 29. 
(12) V. K. Ahluwalia and K. K. Arora, Tetrahedron, 1981, 37, 1437. 
(13) S. W. Youn, Synlett, 2007, 3050. 
(14) I. Mohammadpoor-Baltork, H. Aliyan and A. Reza Khosropour, Tetrahedron, 2001, 57, 5851. 
(15) R. W. Bates, C. J. Gabel, J. Ji and T. Rama-Devi, Tetrahedron, 1995, 51, 8199. 
(16) T. Narender, K. P. Reddy and G. Madhur, Synth. Commun., 2009, 39, 1949. 
(17) V. S. Parmar, S. Gupta, K. S. Bisht, S. Mukherjee, P. M. Boll and W. Errington, Acta Chem. 
Scand., 1996, 50, 558. 
(18) S. Combes, J.-P. Finet and D. Siri, J. Chem. Soc., Perkin Trans. 1, 2002, 38. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S18
 
MeO
MeO
OMe
6a  
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S19
MeO
MeO
OMe
6b  
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S20
MeO
MeO
OMe
8
Br
 
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S21
MeO
MeO
OMe
10
O
OMe
 
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S22
MeO
MeO
OMe
12
O
OMe
 
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S23
MeO
MeO
OMe
14a
O
OMe
 
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S24
MeO
MeO
OMe
14b
O
OMe
 
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S25
MeO
MeO
16
O
OMe
 
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S26
MeO
MeO
18
O
OMe
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S27
O
H3C
O
H3C
H2
C
OMe
O
C
H2
18
A
B  
 
 
 
B A
A 
 
B 
 B                A
A 
 
 
 
B 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S28
O
O
20
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S29
O
OH
O
22
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S30
O
OMe
O
24
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S31
O
O
26
OH
 
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S32
O
HO
27
O
 
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S33
O
O
28
O
 
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S34
MeO
MeO
OMe
O
32  
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S35
O
OMe
MeO
MeO
33  
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S36
MeO
MeO
OMe
O
35a
O
 
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S37
MeO
MeO
OMe
O
35b
O
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S38
MeO
MeO
OMe
OH
31a  
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S39
MeO
MeO
OMe
OH
31b  
 
 
 
Katie E. Judd and Lorenzo Caggiano, Org. Biomol. Chem., 2011, 9, 5201-5210 
 S40
MeO
MeO
OMe
OH
36
O
 
 
 
 
